Fossdal G, Braadland P, Hov JR, Husebye ES, Folseraas T, Ueland PM, Ulvik A, Karlsen TH, Berge RK, Vesterhus M(2025) Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitis Scand J Gastroenterol, 1-9(in press) DOI 10.1080/00365521.2024.2447521, PubMed 39764583
Grimsrud MM, Forster M, Goeppert B, Hemmrich-Stanisak G, Sax I, Grzyb K, Braadland PR, Charbel A, Metzger C, Albrecht T, Steiert TA, Schlesner M, Manns MP, Vogel A, Yaqub S, Karlsen TH, Schirmacher P, Boberg KM, Franke A, Roessler S, Folseraas T(2024) Whole-exome sequencing reveals novel cancer genes and actionable targets in biliary tract cancers in primary sclerosing cholangitis Hepatol Commun, 8(7) DOI 10.1097/HC9.0000000000000461, PubMed 38967597
Poch T, Bahn J, Casar C, Krause J, Evangelakos I, Gilladi H, Kunzmann LK, Laschtowitz A, Iuso N, Schäfer AM, Liebig LA, Steinmann S, Sebode M, Folseraas T, Engesæter LK, Karlsen TH, Franke A, Hubner N, Schlein C, Galun E, Huber S, Lohse AW, Gagliani N, Schwinge D, Schramm C(2024) Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis Cell Rep Med, 5(7), 101620 DOI 10.1016/j.xcrm.2024.101620, PubMed 38901430
